OFM
Omega Fund Management Portfolio holdings
AUM
$154M
This Quarter Return
+5.71%
1 Year Return
-32.78%
3 Year Return
+82.35%
5 Year Return
+29.08%
10 Year Return
+90.46%
AUM
$273M
AUM Growth
+$273M
(-13%)
Cap. Flow
-$61.8M
Cap. Flow
% of AUM
-22.64%
Top 10 Holdings %
Top 10 Hldgs %
90.67%
Holding
21
New
–
Increased
–
Reduced
5
Closed
2
Top Buys
No buys this quarter
Top Sells
| 1 |
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
|
$14.6M |
| 2 |
CINC
CinCor Pharma, Inc. Common Stock
CINC
|
$13.3M |
| 3 |
Arcutis Biotherapeutics
ARQT
|
$13.3M |
| 4 |
MORF
Morphic Holding, Inc. Common Stock
MORF
|
$11.7M |
| 5 |
Replimune Group
REPL
|
$6.65M |
Sector Composition
| 1 | Healthcare | 98.18% |
| 2 | Financials | 1.82% |
